{"id":3909,"date":"2018-02-16T16:24:34","date_gmt":"2018-02-16T21:24:34","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3909"},"modified":"2018-02-16T16:27:19","modified_gmt":"2018-02-16T21:27:19","slug":"ipo-weekly-recap-biofrontera-shines-in-debut","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-biofrontera-shines-in-debut\/","title":{"rendered":"IPO Weekly Recap: Biofrontera shines in debut"},"content":{"rendered":"<p><em><span style=\"font-weight: 400;\">Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the <\/span><b>TRUEST<\/b><span style=\"font-weight: 400;\"> picture of how an IPO is shaping up prior to its debut. We are on <\/span><b>your team. <\/b><span style=\"font-weight: 400;\">Additionally, we provide comprehensive research to outline short and long term risks of the new companies\u2026.. <\/span><b>A full-service firm! <\/b><\/em><\/p>\n<p><span style=\"font-weight: 400;\">This past week two IPOs debuted that came with contrasting debuts.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3910\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM.png\" alt=\"Screen Shot 2018-02-16 at 4.22.34 PM\" width=\"1407\" height=\"108\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM.png 1407w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM-600x46.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM-300x23.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Screen-Shot-2018-02-16-at-4.22.34-PM-1024x79.png 1024w\" sizes=\"(max-width: 1407px) 100vw, 1407px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Of the two deals that came to market, one was a hold-over from the previous week and the other was a biotech offering that currently trades on the <\/span><b>Frankfurt Stock Exchange.<\/b><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BiofronteraAG.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-3911\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/BiofronteraAG.jpg\" alt=\"BiofronteraAG\" width=\"282\" height=\"98\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The<\/span><b> Biofrontera AG (BFRA)<\/b><span style=\"font-weight: 400;\"> was underwritten by Benchmark and priced 1.2mm ADSs at $9.88. The deal opened at $13.00 and traded very well in its opening week as the offering hit new highs above $14.00 in its third session on Friday. BFRA closed at $14.23 for a gain of 44.0% for investors who held through Friday.<\/span><\/p>\n<p><b><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/MotusGi.jpg\"><img decoding=\"async\" class=\"aligncenter size-full wp-image-3862\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/MotusGi.jpg\" alt=\"MotusGi\" width=\"514\" height=\"85\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/MotusGi.jpg 514w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/MotusGi-300x50.jpg 300w\" sizes=\"(max-width: 514px) 100vw, 514px\" \/><\/a>Motus GI Holdings (MOTS) <\/b><span style=\"font-weight: 400;\">priced 3.5mm shares at the low-end of the range, $5.00, and opened flat. MOTS broke its offering price immediately and traded below issue for the rest of the week. MOTS closed at $4.00 for a 20% loss.<\/span><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Farmmi.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-3913\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Farmmi.jpg\" alt=\"Farmmi\" width=\"486\" height=\"214\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Farmmi.jpg 486w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/02\/Farmmi-300x132.jpg 300w\" sizes=\"(max-width: 486px) 100vw, 486px\" \/><\/a><\/p>\n<p>Microcap Farmmi Inc (FAMI) priced 1.68mm shares at $4.00. The company\u00a0processes and sells four categories of agricultural products: Shiitake mushrooms, Mu Er mushrooms, other edible fungi, and other agricultural products. The company experienced several volatility halts but opened Friday at $4.40 and traded to a Friday close of $6.18 for a gain of 54.5% as of the close Friday.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1471,1470],"class_list":["post-3909","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-bfra","tag-mots"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3909"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3909\/revisions"}],"predecessor-version":[{"id":3915,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3909\/revisions\/3915"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}